Kırgızistan’ın yerli halkında lipitler ve leptin düzeyi

Dr. Erkin Mirrakhimov, Dr. Alina Kerimkulova, Dr. Olga Lunegova, Dr. Aibek Mirrakhimov, Dr. Nazira Alibaeva, Dr. Malik Nabiev

Department of Internal Medicine, Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan

National Center of Cardiology and Internal Disease, Bishkek, Kyrgyzstan

Kyrgyz-Russian (Slavic) Univeristy, Bishkek, Kyrgyzstan

Erkin Mirrakhimov

Togolok Moldo 3 Bishkek, Kyrgyzstan. Tel: +90 996312 663175 e-mail:

Gönderim Tarihi: 06 Mayıs 2013

Kabul Tarihi: 06 Ekim 2013

TKD Arşivi 2014, Cilt 42, Sayı 3, Page 253-258, DOI: 10.5543/tkda.2014.39586

Amaç: Adipositler tarafından salgılanan 167 amino asitli protein olan leptin obezite ile bozulmuş lipit metabolizması arasındaki olası bağlantıyı oluşturur. Vücutta leptinin içeriği beden kütle indeksiyle (BKİ) yakından ilişkilidir. Leptinin dislipidemiyle ilişkisi konusundaki çalışmalardan elde edilen veriler çelişkilidir. Kırgız halkında leptin düzeyi daha önce araştırılmamıştır. Bu çalışmanın amacı Kırgız ırkında leptin ile lipit parametreleri arasındaki ilişkiyi araştırmaktır.

Çalışma planı: Çalışmaya Kırgızistan’da yaşayan ≥30 yaşlarında Kırgız ırkından 322 kişi (145 erkek, 177 kadın) alındı. Antropometrik parametreler [boy, kilo, bel çevresi (BÇ), kalça çevresi (KÇ)] ve kan basıncı (KB) ölçüldü. Laboratuvar testlerinden açlık kan şekeri (AKŞ), lipit profili [total kolesterol (TK), trigliseritler (TG), yüksek yoğunluklu lipoprotein (YYL) kolesterol, düşük yoğunluklu kolesterol (DYL) ve serum leptin ölçüldü.

Bulgular: Serum leptin, her iki cinste BKİ, BÇ, TG ve erkeklerde TK ile pozitif korelasyon göstermektedir.

Sonuç: Leptin, Kırgızlarda her iki cinste BKİ, BÇ ve TK, erkeklerde TK ile ilişkilidir.

Anahtar Kelimeler:

Beden kütle indeksi; leptin; lipitler; Kırgızistan; bel çevresi.


Obesity is associated with dyslipidemia and cardiovascular disease.[1] However, the underlying mechanisms of this association are not fully understood. A possible link between obesity and impaired lipid metabolism may be found through the molecule leptin, a 167-amino acid protein, secreted by adipocytes.[ 2] Since 1994,[2] leptin has attracted the attention of researchers as it was found that its content in the body reflects the amount of energy reserves accumulated in adipose tissue and is closely associated with body mass index (BMI).[3] In contrast, data obtained from studies on the association of leptin with dyslipidemia are contradictory.[4] Some studies have found a positive correlation of leptin with triglycerides (TG) and no relation to high-density lipoprotein cholesterol (HDL-C).[5,6] On the other hand, some studies have found a correlation of leptin only with HDL-C. [7] The level of leptin has not been studied previously in the ethnic Kyrgyz population. Thus, the purpose of this study was to investigate the relationship between leptin and lipid parameters in a group of ethnic Kyrgyz.


Study population

This cross-sectional study assessing the prevalence of cardiovascular risk factors was conducted from April to July 2008 and included adult persons from the general population permanently living in Kyrgyzstan. Exclusion criteria included those who underwent surgery within one month prior to the study; those with severe chronic diseases of the liver and/or kidney; those with thyroid dysfunction; patients currently receiving treatment with corticosteroids, lipid-lowering drugs, or insulin; pregnant women; and persons of non-Kyrgyz ethnicity. In total, 322 native ethnic Kyrgyz (145 males, 177 females) aged ≥30 years were included in the present study.

All participants gave written informed consent for the study. The study protocol was approved by the Ethical Committee of the National Center of Cardiology and Internal Medicine. All persons were examined by a cardiologist with collection of complaints, medical history, and physical examination, including measurement of anthropometric parameters (height, weight, waist circumference [WC], hip circumference) and blood pressure (BP). BMI was calculated using the formula: BMI = weight (kg) / height (m)2. Obesity was defined if BMI was ≥30 kg/m2 and abdominal obesity (AO) if WC was ≥102 cm in males and ≥88 cm in females.[1]

Laboratory analysis

Blood samples for laboratory tests were taken in the morning on an empty stomach. Biochemical analyses were carried out in the Dir Adjoint du Département Hommes, Natures, Musée de l’Homme (Paris, France) and included blood glucose in plasma and serum lipid profile (total cholesterol (TC), TG, HDL-C). The concentration of low-density lipoprotein cholesterol (LDL-C) was calculated with the Friedewald formula.[ 8] Serum leptin level was assessed using solidphase enzyme immunoassay (ELISA) (DRG Instruments GmbH, Germany). Hypertriglyceridemia was defined if TG level was ≥1.7 mmol/L and low HDL level if <1.03 mmol/L in males and <1.3 mmol/L in females.

Statistical analysis

Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS) 12.0 (SPSS, Inc., Chicago, IL). Comparison of variables with a normal distribution was performed using a set Student t test and results are presented as mean ± standard deviation. Variables with nonparametric distribution were compared using the Mann-Whitney test and are presented with median values (25th and 75th percentile). Kruskal-Wallis ANOVA test was used to compare the differences among three groups. The relationship between variables was assessed by Spearman rank correlation. A p-value <0.05 was considered to be statistically significant.


Clinical characteristics of the patients enrolled in the study are presented in Table 1.

The mean age was 51.7±9.6 years, and the median leptin level was 7.8 ng/ml. 29.2% of the included persons had obesity, 41.9% had arterial hypertension, 42.2% had AO, and 6.8% suffered from type 2 diabetes (Table 1). Analysis of lipids showed hypertriglyceridemia in 30.1% of patients and low HDL-C in 59.9% of the study participants.

In order to evaluate the association of leptin levels with cardiometabolic risk factors, all participants were stratified into three groups based on tertile of leptin (males: <3.0; 3.0-5.51; ≥5.52 ng/ml (Table 2); females: <9.6; 9.6-16.6; ≥16/7 ng/ml (Table 3).

Comparative analysis of the groups showed that males in the upper tertile of leptin had high values of BMI, WC, WC/HC and glycemia compared to patients with lower leptin levels. The frequency of obesity and AO increased with higher levels of leptin. The abovedescribed pattern was traced for females as well, although the age of the groups was comparable.

Analysis of the lipid parameters showed significant differences in TG level in both males (p<0.001) and females (p=0.02). The other lipid profile components were comparable between tertiles in both sexes, except for TC in males (p=0.001) (Tables 2, 3).

Next, Spearman correlation was performed between leptin, anthropometric data and laboratory parameters (Table 4). No correlation of leptin with age was revealed. In patients of both sexes, leptin positively correlated with BMI, WC, TG, and glucose concentrations. However, leptin correlated with TC in males, and negatively correlated with HDL-C in females (Table 4).


Leptin is secreted mainly by adipose tissue. As an important body weight regulator, it promotes various physiological mechanisms in accordance with the state of energy balance, and informs the hypothalamus about the energy stored in the adipocytes. Leptin plays an important role in the regulation of feeding behavior: its concentration decreases in a state of hunger and increases after a meal.[9] It is known that leptin level reflects the amount of adipose tissue in the body, and hyperleptinemia is typical for alimentary obesity and АО.[10]

In the present study, serum leptin was significantly associated with general and abdominal obesity. In addition, a strong correlation was observed between leptin levels and BMI in both sexes. In our study, the leptin level in females was 3.1 times higher than in males. Similar results were shown in other studies. [11,12] Gender differences in leptin may be due to the action of sex hormones: it is thought that androgens have a suppressive effect on the leptin concentration. [13] The studies on the association of leptin with estrogen and progesterone showed conflicting results. [14,15] At the same time, higher leptin levels in females may be due to the influence of other factors, such as the structural differences in the hypothalamus[16] and the higher content of subcutaneous adipose tissue in women.[13,17] It is known that leptin is predominantly secreted by subcutaneous adipocytes,[18] and in some studies, its association with subcutaneous fat tissue was much stronger than with the visceral tissue.[19]

Studies on the association of serum leptin and lipids have shown conflicting results. Some studies found no relation of leptin to the parameters of the lipid profile.[20,21] Other studies have shown a significant positive correlation between leptin and HDL-C[7,22] and TG.[5,10] In the present study, a positive correlation was found between leptin and TC in males and a weak negative correlation with HDL-C in females, which is probably due to the higher prevalence of hypercholesterolemia and decreased HDL-C in males and females, respectively. At the same time, among patients of both sexes, leptin level was significantly correlated with TG blood concentration.

Indeed, TG is stored in adipose tissue as the main form of energy, and there is a strong correlation between the TG blood concentration and adipose tissue deposition. Thus, its association with leptin may be indirect through the presence of obesity.[23-25] In addition, some studies have shown that leptin is associated with the factors responsible for lipid metabolism. Hyperleptinemia is associated with increased synthesis and decreased cholesterol absorption.[26] Cohen et al.[27] also demonstrated that leptin can specifically inhibit the gene encoding stearoyl coenzyme A desaturase- 1 - the enzyme involved in the synthesis of TG and a very low-density lipoprotein in the liver. However, the exact mechanisms of leptin regulation of lipid synthesis in the liver are not fully understood and require further research.

Previous studies have shown that leptin levels vary by ethnicity. The highest leptin level was reported in South Asian (Indian) people in several studies,[28-30] and was significantly higher compared with persons of Caucasian and Chinese ancestry, independent of age and BMI. African-American subjects were also reported to have greater mean levels of leptin[31] compared with Caucasians, Hispanics and those of Chinese origin. In Chinese people, the level of leptin was lower than in other ethnic groups.[28,31,32] In addition, it was also shown that the unit change in leptin per unit change in BMI differed across ethnic groups and was significantly higher in the Chinese subgroup.[31]

In conclusion, hyperleptinemia, especially in patients with obesity, should be seen as a sign of energy imbalance of carbohydrate and lipid metabolism associated with the development of cardiovascular disease and type 2 diabetes mellitus. Obviously, leptin, as a biomarker for body fat, reflects a hitherto unexplored activity of adipocytes and contains important information about the risk of cardiovascular disease.[33] The results of our study show that leptin is associated with general and abdominal obesity and dyslipidemia. However, further large-scale prospective studies are necessary to better understand and closely examine the physiological and pathological functions of leptin.


The authors thank E. Heyer, Dir Adjoint du Département Hommes, Natures, Musée de l’Homme (Paris, France) for performing the biochemical analyses. No potential conflicts of interest relevant to this article are reported.

Conflict-of-interest issues regarding the authorship or article: None declared

1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 2006;21:1-6.

2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32.

3. Soufi M, Sattler AM, Herzum M, Maisch B, Schaefer JR. Molecular basis of obesity and the risk for cardiovascular disease. Herz 2006;31:200-6.

4. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 2005;126:121-9.

5. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998;18:928-33.

6. Couillard C, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, et al. Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study Diabetes Care 1998;21:782-6.

7. Chapman IM, Wittert GA, Norman RJ. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Clin Endocrinol (Oxf) 1997;46:175-81.

8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.

9. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004;50:1511-25.

10. Sinha MK, Opentanova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J, et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996;98:1277-82.

11. Hu FB, Chen C, Wang B, Stampfer MJ, Xu X. Leptin concentrations in relation to overall adiposity, fat distribution, and blood pressure in a rural Chinese population. Int J Obes Relat Metab Disord. 2001;25:121-5.

12. Martins Mdo C, Lima Faleiro L, Fonseca A. Relationship between leptin and body mass and metabolic syndrome in an adult population. [Article in Portuguese] Rev Port Cardiol 2012;31:711-9. [Abstract]

13. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996;81:3424-7.

14. Shimizu H, Shimomura Y, Nakanishi Y, Futawatari T, Ohtani K, Sato N, et al. Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol 1997;154:285-92.

15. Haffner SM, Mykkänen L, Stern MP. Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy. Am J Epidemiol 1997;146:581-5.

16. Sheu WH, Lee WJ, Chen YT. High plasma leptin concentrations in hypertensive men but not in hypertensive women. J Hypertens 1999;17:1289-95.

17. Ingelsson E, Larson MG, Yin X, Wang TJ, Meigs JB, Lipinska I, et al. Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community- based sample. J Clin Endocrinol Metab 2008;93:3149- 57.

18. Kotani K, Tokunaga K, Fujioka S, Kobatake T, Keno Y, Yoshida S, et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 1994;18:207-2.

19. Park KG, Park KS, Kim MJ, Kim HS, Suh YS, Ahn JD, et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 2004;63:135-42.

20. Haluzík M, Fiedler J, Nedvídková J, Ceska R. Serum leptin levels in patients with hyperlipidemias. Nutrition 2000;16:429-33.

21. al-Shoumer KA, Anyaoku V, Richmond W, Johnston DG. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf) 1997;47:153-9.

22. Rainwater DL, Comuzzie AG, VandeBerg JL, Mahaney MC, Blangero J. Serum leptin levels are independently correlated with two measures of HDL. Atherosclerosis 1997;132:237- 43.

23. Rosenbaum M, Leibel RL. Pathophysiology of childhood obesity. Adv Pediatr 1988;35:73-137.

24. Rosenbaum M, Leibel RL. The role of leptin in human physiology. N Engl J Med 1999;341:913-5.

25. Comizio R, Pietrobelli A, Tan YX, Wang Z, Withers RT,Heymsfield SB, et al. Total body lipid and triglyceride response to energy deficit: relevance to body composition models. Am J Physiol 1998;274:860-6.

26. Hallikainen M, Kolehmainen M, Schwab U, Laaksonen DE, Niskanen L, Rauramaa R, et al. Serum adipokines are associated with cholesterol metabolism in the metabolic syndrome. Clin Chim Acta. 2007;383:126-32.

27. Cohen P, Friedman JM. Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1). J Nutr 2004;134:2455-2463.

28. Mente A, Razak F, Blankenberg S, Vuksan V, Davis AD, Miller R, et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 2010;33:1629-34.

29. Liew CF, Seah ES, Yeo KP, Lee KO, Wise SD. Lean, nondiabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects. Int J Obes Relat Metab Disord 2003;27:784-9.

30. Patel JV, Sosin M, Lim HS, Chung I, Panja N, Davis RC, et al. Raised leptin concentrations among South Asian patients with chronic heart failure. Int J Cardiol 2007;122:34-40.

31. Rasmussen-Torvik LJ, Wassel CL, Ding J, Carr J, Cushman M, Jenny N, et al. Associations of body mass index and insulin resistance with leptin, adiponectin, and the leptin-to-adiponectin ratio across ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). Ann Epidemiol 2012;22:705-9.

32. Zhang R, Liao E, Wu X, Xie H, Shan P, Zhang H, et al. Concentration of serum leptin and age in Chinese women and comparison with other races. [Article in Chinese] Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009;34:1136-41. [Abstract]

33. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001;104:3052-6.

© 2015 Türk Kardiyoloji Derneği. Tüm hakları saklıdır. Bu sitedeki içerikler sağlık profesyonelleri için hazırlanmıştır.